Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 27, 1999

View Archived Issues

Commission Calls For Stricter EU Restrictions On GM Foods

Genset Signs New Deal With GI To Include Gene Library Access

Fouron Resigns From IDM

Thallia Forced To Close Shop After Failing To Get Financing

Swiss Researchers Elucidate Mediation Of GABA Subtypes

Canadian Group Uses Toxins To Remove Cancer From Cells

Hepavec Gets Option On Ovine Adenovirus For Gene Therapy

Wellcome Trust Invests #10M To Help Identify Cancer Genes

BIA Members Agree To Code Governing Communications

ExonHit Launches Product That Assesses Toxicology

Irish Minister Reveals U.S. Lobbied On Behalf Of GMOs

D-Pharm Named Top Startup Company In Israeli Healthcare

Prolifix Enters Collaboration On Factor With Lilly, Chugai

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...